NOTCH3 and ovarian carcinoma: Taken together, the restoration of miR-150 induces the drug-resistant ovarian cancer cells to regain the sensitivity to PTX, and inhibits cancer cell migration and proliferation, at least partly by the repression of its target gene, Notch3, and its downstream proteins.